CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 78 enrolled
Drug / intervention
continuous infusion +3 moredrug
Likely dose
ketorolac 0.5 mg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02112448
NCT02112448N/ACompleted

Continuous Infusion Versus Bolus Dosing for Pain Control After Pediatric Cardiothoracic Surgery

Wake Forest University Health Sciences·interventional·Posted Apr 14, 2014·Updated Oct 24, 2024

In Brief

A clinical study evaluating continuous infusion, as needed dosing, and 2 other interventions for Congenital Heart Disease. Completed, enrolled 78 participants across 1 site.

Detailed Summary

The investigators hypothesize that intermittent bolus doses of morphine and midazolam can provide the same pain control after pediatric cardiothoracic surgery as bolus doses plus infusions while using smaller total doses of both medications. The investigators will randomize patients to receive either morphine/midazolam as needed intermittently or morphine/midazolam drips plus intermittent doses to be received as needed. Pain scores will be recorded and total medications given will be recorded.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedApr 14, 2014
Enrollment StartJun 1, 2014
Primary CompletionMay 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 12.2 years ago

Interventions

continuous infusiondrug

Continuous morphine/midazolam and 'as needed' doses. Will receive scheduled acetaminophen and ketorolac.

as needed dosingdrug

morphine and midazolam as needed. Will receive scheduled acetaminophen and ketorolac..

Acetaminophendrug

Acetaminophen will be given every 4 hours for a total of 24 hours.

ketorolacdrug

Ketorolac 0.5 mg/kg will be given every six hours to all subjects in the study.